Dr. Reddy's Files FDA ANDA For UCB Epilepsy Drug
Indian drug maker Dr. Reddy's Laboratories has filed an abbreviated new drug application with the United States Food and Drug Administration for levetiracetam, a generic form of Belgian pharmaceutical company UCB's...To view the full article, register now.
Already a subscriber? Click here to view full article